27452398|t|Protective effect of epigallocatechin-3-gallate (EGCG) via Nrf2 pathway against oxalate -induced epithelial mesenchymal transition (EMT) of renal tubular cells
27452398|a|This study evaluated effect of oxalate on epithelial mesenchymal transition (EMT) and potential anti-fibrotic property of epigallocatechin-3-gallate (EGCG). MDCK renal tubular cells were incubated with 0.5 mM sodium oxalate for 24-h with/without 1-h pretreatment with 25 Î¼M EGCG. Microscopic examination, immunoblotting and immunofluorescence staining revealed that oxalate -treated cells gained mesenchymal phenotypes by fibroblast -like morphological change and increasing expression of vimentin and fibronectin, while levels of epithelial markers (E-cadherin, occludin, cytokeratin and ZO-1) were decreased. EGCG pretreatment could prevent all these changes and molecular mechanisms underlying the prevention by EGCG were most likely due to reduced production of intracellular ROS through activation of Nrf2 signaling and increased catalase anti-oxidant enzyme. Knockdown of Nrf2 by small interfering RNA (siRNA) abrogated all the effects of EGCG, confirming that the EGCG protection against oxalate -induced EMT was mediated via Nrf2. Taken together, our data indicate that oxalate turned on EMT of renal tubular cells that could be prevented by EGCG via Nrf2 pathway. These findings also shed light onto development of novel therapeutics or preventive strategies of renal fibrosis in the future.
27452398	21	47	epigallocatechin-3-gallate	T103	UMLS:C0059438
27452398	49	53	EGCG	T103	UMLS:C0059438
27452398	59	63	Nrf2	T103	UMLS:C0289507
27452398	64	71	pathway	T038	UMLS:C1704259
27452398	80	87	oxalate	T103	UMLS:C0029988
27452398	97	130	epithelial mesenchymal transition	T038	UMLS:C1523298
27452398	132	135	EMT	T038	UMLS:C1523298
27452398	140	145	renal	T017	UMLS:C0022646
27452398	165	170	study	T062	UMLS:C2603343
27452398	191	198	oxalate	T103	UMLS:C0029988
27452398	202	235	epithelial mesenchymal transition	T038	UMLS:C1523298
27452398	237	240	EMT	T038	UMLS:C1523298
27452398	256	278	anti-fibrotic property	T033	UMLS:C0243095
27452398	282	308	epigallocatechin-3-gallate	T103	UMLS:C0059438
27452398	310	314	EGCG	T103	UMLS:C0059438
27452398	317	341	MDCK renal tubular cells	T017	UMLS:C0598829
27452398	347	356	incubated	T058	UMLS:C0022885
27452398	369	383	sodium oxalate	T103	UMLS:C0087001
27452398	434	438	EGCG	T103	UMLS:C0059438
27452398	440	463	Microscopic examination	T058	UMLS:C0026018
27452398	465	479	immunoblotting	T058	UMLS:C0020985
27452398	484	511	immunofluorescence staining	T058	UMLS:C0079603
27452398	526	533	oxalate	T103	UMLS:C0029988
27452398	543	548	cells	T017	UMLS:C0007634
27452398	556	567	mesenchymal	T017	UMLS:C0162415
27452398	582	592	fibroblast	T017	UMLS:C0016030
27452398	599	619	morphological change	T017	UMLS:C1260954
27452398	635	645	expression	T038	UMLS:C1171362
27452398	649	657	vimentin	T103	UMLS:C0042666
27452398	662	673	fibronectin	T103	UMLS:C0016055
27452398	691	709	epithelial markers	T103	UMLS:C0033684
27452398	711	721	E-cadherin	T103	UMLS:C0042172
27452398	723	731	occludin	T103	UMLS:C0250400
27452398	733	744	cytokeratin	T103	UMLS:C0010803
27452398	749	753	ZO-1	T103	UMLS:C3503764
27452398	771	775	EGCG	T103	UMLS:C0059438
27452398	825	845	molecular mechanisms	T038	UMLS:C3537153
27452398	875	879	EGCG	T103	UMLS:C0059438
27452398	912	922	production	T038	UMLS:C3714634
27452398	926	943	intracellular ROS	T103	UMLS:C0162772
27452398	966	970	Nrf2	T103	UMLS:C0289507
27452398	971	980	signaling	T038	UMLS:C3537152
27452398	995	1023	catalase anti-oxidant enzyme	T103	UMLS:C0007367
27452398	1025	1034	Knockdown	T062	UMLS:C2350567
27452398	1038	1042	Nrf2	T017	UMLS:C1417701
27452398	1046	1067	small interfering RNA	T103	UMLS:C1099354
27452398	1069	1074	siRNA	T103	UMLS:C1099354
27452398	1105	1109	EGCG	T103	UMLS:C0059438
27452398	1131	1135	EGCG	T103	UMLS:C0059438
27452398	1155	1162	oxalate	T103	UMLS:C0029988
27452398	1172	1175	EMT	T038	UMLS:C1523298
27452398	1193	1197	Nrf2	T103	UMLS:C0289507
27452398	1238	1245	oxalate	T103	UMLS:C0029988
27452398	1256	1259	EMT	T038	UMLS:C1523298
27452398	1263	1268	renal	T017	UMLS:C0022646
27452398	1310	1314	EGCG	T103	UMLS:C0059438
27452398	1319	1323	Nrf2	T103	UMLS:C0289507
27452398	1324	1331	pathway	T038	UMLS:C1704259
27452398	1431	1445	renal fibrosis	T038	UMLS:C0151650